ARTICLE | Clinical News
Arresto BioSciences preclinical data
September 6, 2010 7:00 AM UTC
In a mouse model of liver fibrosis, AB0023 significantly increased survival vs. vehicle-treated controls (p=0.006). The mAb against lysyl oxidase-like 2 (LOXL2) also significantly reduced porto-porta...